# Avalo Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/avalo-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-15T04:46:15.111471+00:00 | | Last reviewed | 2026-10-15T04:46:15.111471+00:00 | ## Identity - Legal name: Avalo Therapeutics, Inc. - Display name: Avalo Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T04:14:06.033937+00:00 | | Completeness | 0.409 | | Record Quality | 0.844 | | Directors | 7 | | Committees | 6 | | Governance events | 19 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Aaron Kantoff: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:5 - Garry Neil, M.D.: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:6 - Gilla Kaplan, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:7 - Kevin Lind: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:8 - Michael Heffernan: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:9 - Rita Jain, MD: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:10 - Samantha Truex: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:11 ## Committees - Audit (audit). Chair: Kevin Lind. Members: Kevin Lind (chair, current). committee_id=alpha:committee:avalo-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Kevin Lind (member, current). committee_id=alpha:committee:avalo-therapeutics-inc:audit-chair-compensation - Compensation (compensation). Chair: Aaron Kantoff. Members: Aaron Kantoff (chair, current); Kevin Lind (member, current); Samantha Truex (member, current). committee_id=alpha:committee:avalo-therapeutics-inc:compensation - Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Aaron Kantoff (member, current). committee_id=alpha:committee:avalo-therapeutics-inc:compensation-chair-nominating-and-governance - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Samantha Truex (member, current). committee_id=alpha:committee:avalo-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Samantha Truex. Members: Samantha Truex (chair, current); Aaron Kantoff (member, current). committee_id=alpha:committee:avalo-therapeutics-inc:nominating-and-governance ## Executive leadership - Christopher Sullivan: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:12 - Garry Neil, M.D.: Chief Executive Officer, President, Chairman of the Board [CEO]. Status: current. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:13 - Jennifer Riley: Chief Strategy Officer. Status: current. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:14 - Mittie Doyle, M.D., FACR: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:15 - Paul Varki: Chief Legal Officer [GC]. Status: current. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:16 - Taylor Boyd: Chief Business Officer. Status: current. claim_id=alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:17 ## Governance events - CFO_CHANGED: Christopher Sullivan executive of Avalo Therapeutics, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1dvtegolzxbu2 - CEO_CHANGED: Garry Neil, M.D. executive of Avalo Therapeutics, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:vn01zh1uumtmz - EXECUTIVE_APPOINTED: Jennifer Riley executive of Avalo Therapeutics, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:b69582izy5i6 - EXECUTIVE_APPOINTED: Mittie Doyle, M.D., FACR executive of Avalo Therapeutics, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:cbcpe0lspjqk - GC_CHANGED: Paul Varki executive of Avalo Therapeutics, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1sh1mzax0hmsu - EXECUTIVE_APPOINTED: Taylor Boyd executive of Avalo Therapeutics, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:j5hncdt1btaz - DIRECTOR_APPOINTED: Kevin Lind seat on Avalo Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:138hu36ip7g4y - DIRECTOR_APPOINTED: Michael Heffernan seat on Avalo Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1xwc46rujr543 - DIRECTOR_APPOINTED: Rita Jain, MD seat on Avalo Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:119et6h20r89j - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Avalo Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:4v57bw19s9etq - COMMITTEE_MEMBER_ADDED: Kevin Lind member of Audit · Chair; Compensation, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1waz07x17gjuch - DIRECTOR_APPOINTED: Aaron Kantoff seat on Avalo Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1d6ee3c5m7dhm - DIRECTOR_APPOINTED: Samantha Truex seat on Avalo Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:uzrzzb1chg85n - COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of Avalo Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1yzyldg5prk2i - COMMITTEE_MEMBER_ADDED: Aaron Kantoff member of Compensation · Chair; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1wy4h91v5g7v3 - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Avalo Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:upxhv5rvc43j - COMMITTEE_MEMBER_ADDED: Samantha Truex member of Compensation; Nominating and Governance · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:522y1o1o4pozu - DIRECTOR_APPOINTED: Garry Neil, M.D. seat on Avalo Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:1nrgcmb2lieiz - DIRECTOR_APPOINTED: Gilla Kaplan, Ph.D. seat on Avalo Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:46:15.111471+00:00. event_id=alpha:event:transition:92mt7617h3mdg ## Scoped resources - `alpha://company/avalo-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record - `alpha://company/avalo-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=identity - `alpha://company/avalo-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/avalo-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=board - `alpha://company/avalo-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=committees - `alpha://company/avalo-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=leadership - `alpha://company/avalo-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=ownership - `alpha://company/avalo-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=financials - `alpha://company/avalo-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/avalo-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=compensation - `alpha://company/avalo-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=governance - `alpha://company/avalo-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/avalo-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=audit - `alpha://company/avalo-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=legal - `alpha://company/avalo-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=risk - `alpha://company/avalo-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=cyber - `alpha://company/avalo-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/avalo-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=agents - `alpha://company/avalo-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/avalo-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=events - `alpha://company/avalo-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=relationships - `alpha://company/avalo-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=assessments - `alpha://company/avalo-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:kevin-lind","name":"Kevin Lind"},"source_id":"board_seats"}` - Claim alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:aaron-kantoff","name":"Aaron Kantoff"},"source_id":"board_seats"}` - Claim alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kevin-lind","name":"Kevin Lind"},"source_id":"board_seats"}` - Claim alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:samantha-truex","name":"Samantha Truex"},"source_id":"board_seats"}` - Claim alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:samantha-truex","name":"Samantha Truex"},"source_id":"board_seats"}` - Claim alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:aaron-kantoff","name":"Aaron Kantoff"},"source_id":"board_seats"}` ## Leadership - Aaron Kantoff: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Garry Neil, M.D.: Director. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Gilla Kaplan, Ph.D.: Director. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Kevin Lind: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Michael Heffernan: Director. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Rita Jain, MD: Director. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Samantha Truex: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66. - Christopher Sullivan: Chief Financial Officer. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:12. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8b7d5600451594702af746bff56f68379ea2ed5af36acd77360b678ed5273c2c. - Garry Neil, M.D.: Chief Executive Officer, President, Chairman of the Board. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:13. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b19a82f8613f2ef8fe6f707422e1ac68ccb4f04142985440c6409224eb7b2625. - Jennifer Riley: Chief Strategy Officer. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:14. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a49aca0a54bdd430de20cb4cd9eac92cd2c64d14e8c359397c304e650220565d. - Mittie Doyle, M.D., FACR: Chief Medical Officer. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:15. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:52bf21d5233de11119d96fe0263f9b390c3c2bc83a62368294df8cae7199478c. - Paul Varki: Chief Legal Officer. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:16. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c4d1cd03c68dbfb8afbe7ae60982e7cc61bab20dd91c8f4716766f4ceeb2a38a. - Taylor Boyd: Chief Business Officer. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:17. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:887ce874f45629f9e203da039bfcb30d888c8bb3dca035734e64b98d73481a12. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Kevin Lind; Members Kevin Lind (Chair). Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Compensation: Chair Aaron Kantoff; Members Aaron Kantoff (Chair); Kevin Lind; Samantha Truex. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Nominating and Governance: Chair Samantha Truex; Members Samantha Truex (Chair); Aaron Kantoff. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Avalo Therapeutics, Inc.. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:548d227081337549d503016e900cc832ca95e3739dea47af3e1e37820d84a7fe. ## Entity Status - Public listing published. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:548d227081337549d503016e900cc832ca95e3739dea47af3e1e37820d84a7fe. ## Published Fact - US. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:548d227081337549d503016e900cc832ca95e3739dea47af3e1e37820d84a7fe. ## Committee Appointment - Kevin Lind: chair, Audit. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Aaron Kantoff: chair, Compensation. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Kevin Lind: member, Compensation. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Samantha Truex: member, Compensation. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Samantha Truex: chair, Nominating and Governance. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. - Aaron Kantoff: member, Nominating and Governance. Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3. ## Security Listing - AVTX (NASDAQ). Claim: alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:548d227081337549d503016e900cc832ca95e3739dea47af3e1e37820d84a7fe. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:548d227081337549d503016e900cc832ca95e3739dea47af3e1e37820d84a7fe: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/avalo-therapeutics-inc). - alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66: [Avalo Therapeutics, Inc. DEF 14A 2026-04-10](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm). - alpha:projection-evidence:document:8b7d5600451594702af746bff56f68379ea2ed5af36acd77360b678ed5273c2c: [AVTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm). - alpha:projection-evidence:document:b19a82f8613f2ef8fe6f707422e1ac68ccb4f04142985440c6409224eb7b2625: [AVTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm). - alpha:projection-evidence:document:a49aca0a54bdd430de20cb4cd9eac92cd2c64d14e8c359397c304e650220565d: [AVTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm). - alpha:projection-evidence:document:52bf21d5233de11119d96fe0263f9b390c3c2bc83a62368294df8cae7199478c: [AVTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm). - alpha:projection-evidence:document:c4d1cd03c68dbfb8afbe7ae60982e7cc61bab20dd91c8f4716766f4ceeb2a38a: [AVTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm). - alpha:projection-evidence:document:887ce874f45629f9e203da039bfcb30d888c8bb3dca035734e64b98d73481a12: [AVTX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm). - alpha:projection-evidence:c8e3b7b6aac2d4c05326f557a986fb08c462b0d6530777bc7b8419d8a11d47d3: [Audit](https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/avalo-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/avalo-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/avalo-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T04:14:05.84635+00:00; recorded 2026-10-16T04:14:05.84635+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.